X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-08 | AVTR | Eck Steven W | SVP, Chief Accounting Officer | S - Sale | $25.63 | -3,685 | 34,406 | -10% | -$94,447 | ||||||
2024-02-29 | AVTR | Bramwell James | EVP Sales, Customer Excellence | S - Sale | $24.52 | -4,910 | 96,233 | -5% | -$120,393 | ||||||
2024-02-29 | AVTR | Couturier Christophe | EVP, AMEA | S - Sale | $24.53 | -13,074 | 83,889 | -13% | -$320,705 | ||||||
| D | 2024-02-27 | AVTR | Bramwell James | EVP Sales, Customer Excellence | S - Sale+OE | $24.49 | -6,203 | 101,143 | -6% | -$151,911 | |||||
2023-09-07 | AVTR | Eck Steven W | SVP, Chief Accounting Officer | S - Sale | $20.64 | -7,577 | 28,187 | -21% | -$156,389 | ||||||
2023-08-25 | AVTR | Vanderhaegen Frederic | EVP, Americas, Europe | S - Sale | $21.47 | -25,000 | 160,735 | -13% | -$536,750 | ||||||
2023-04-11 | AVTR | Couturier Christophe | EVP, AMEA | S - Sale | $21.18 | -1,498 | 98,650 | -1% | -$31,728 | ||||||
2023-03-03 | AVTR | Brophy Gerard | EVP, Biopharma Production | S - Sale | $25.00 | -3,914 | 108,715 | -3% | -$97,850 | ||||||
2023-02-27 | AVTR | Brophy Gerard | EVP, Biopharma Production | S - Sale | $25.00 | -3,059 | 112,629 | -3% | -$76,475 | ||||||
2023-02-28 | AVTR | Couturier Christophe | EVP, AMEA | S - Sale | $24.32 | -2,324 | 100,717 | -2% | -$56,520 | ||||||
| D | 2023-02-23 | AVTR | Couturier Christophe | EVP, AMEA | S - Sale+OE | $24.24 | -3,078 | 103,041 | -3% | -$74,611 | |||||
2023-02-22 | AVTR | Couturier Christophe | EVP, AMEA | S - Sale | $24.12 | -19,160 | 97,160 | -16% | -$462,139 | ||||||
2023-02-02 | AVTR | Brophy Gerard | EVP, Biopharma Production | S - Sale | $25.06 | -11,339 | 102,385 | -10% | -$284,155 | ||||||
2022-11-16 | AVTR | Szlosek Thomas A | EVP, CFO | P - Purchase | $20.71 | +12,500 | 242,601 | +5% | +$258,850 | ||||||
2022-11-16 | AVTR | Stubblefield Michael | CEO | P - Purchase | $20.95 | +15,000 | 1,619,341 | +1% | +$314,250 | ||||||
2022-05-20 | AVTR | Brophy Gerard | EVP, Biopharma Production | S - Sale | $31.27 | -19,603 | 96,935 | -17% | -$612,986 | ||||||
2022-05-23 | AVTR | Vanderhaegen Frederic | EVP, Americas, Europe | S - Sale | $31.61 | -39,000 | 126,764 | -24% | -$1,232,790 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |